Exploration Capital Fund, LP - 04 Dec 2023 Form 4 Insider Report for Fresh Tracks Therapeutics, Inc.

Role
10%+ Owner
Signature
Stephen L. Gustin on behalf of Exploration Capital Fund, LP
Issuer symbol
N/A
Transactions as of
04 Dec 2023
Net transactions value
-$26,362
Form type
4
Filing time
06 Dec 2023, 21:45:07 UTC
Previous filing
06 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FRTX Common Stock Purchase $6,442 -7,579 -1.1% $0.8500 677,579 04 Dec 2023 Direct F1, F2
transaction FRTX Common Stock Purchase $4,410 -5,188 -0.75% $0.8500 682,767 05 Dec 2023 Direct F1, F2
transaction FRTX Common Stock Purchase $15,510 -17,233 -2.4% $0.9000 700,000 06 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exploration Capital, LLC ("X-Cap") is the investment manager of Exploration Capital Fund, LP (the "Partnership") and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Exploration Capital General Partner, LLC (the "GP") is the general partner of the Partnership and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership.
F2 Stephen L. Gustin is the Managing Partner of X-Cap and as a result may be deemed to be the beneficial owner of all the securities held by the Partnership. Mr. Gustin disclaims beneficial ownership of the reported securities held by the Partnership except to the extent of his pecuniary interest.